Abstract
Previous studies have demonstrated that benefits of intensive statin therapy compared to standard statin therapy begin shortly after an acute event and are continued up to 2 years of follow-up. However, whether efficacy and safety of intensive statin therapy in patients with a recent cardiac event are maintained in longer-term follow-up has not been evaluated. We conducted a post hoc analysis of a subgroup of 999 patients who had a first acute myocardial infarction (MI) <2 months before randomization in a prospective, open-label, blinded end-point evaluation trial of 8,888 patients with a history of MI that compared intensive statin therapy (atorvastatin 80 mg) to standard statin therapy (simvastatin 20 to 40 mg) over approximately 5 years of follow-up. We analyzed the same composite end point used in the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT) trial (death, MI, hospitalization for unstable angina, revascularization, and stroke). Rates of the composite end point were 44.7% (n = 226) in the simvastatin group and 37.9% (n = 187) in the atorvastatin group (hazard ratio 0.82, 95% confidence interval 0.67 to 0.99, p = 0.04). Although statistical power was smaller than that of the PROVE IT trial, the r...Continue Reading
References
Aug 1, 1992·Blood Pressure·L HanssonB Dahlöf
Apr 13, 2001·JAMA : the Journal of the American Medical Association·G G SchwartzUNKNOWN Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
Mar 10, 2004·The New England Journal of Medicine·Christopher P CannonUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
Aug 13, 2004·The New England Journal of Medicine·Pim van der HarstDirk J van Veldhuisen
Sep 1, 2004·JAMA : the Journal of the American Medical Association·James A de LemosUNKNOWN Investigators
Sep 18, 2004·The American Journal of Cardiology·Terje R PedersenUNKNOWN Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group
Nov 17, 2005·JAMA : the Journal of the American Medical Association·Terje R PedersenUNKNOWN Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group
May 4, 2006·JAMA : the Journal of the American Medical Association·Matthias BrielAlain J Nordmann
Jan 15, 2008·Journal of the American College of Cardiology·Elliott M AntmanClyde W Yancy
Mar 27, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Ingar HolmeUNKNOWN Incremental Decrease in End Points Through Aggressive Lipid Lowering Study Group
Oct 3, 2009·Journal of the American College of Cardiology·Ryan P MorrisseySanjay Kaul
Citations
Nov 2, 2011·Internal and Emergency Medicine·Diego Vanuzzo
Jul 12, 2011·Current Opinion in Lipidology·Alberico L CatapanoAngela Pirillo
Apr 8, 2011·Clinical Interventions in Aging·Sydney B LongErin D Michos
Jul 18, 2012·Drugs·Carmen GelsingerUrsula Kassner
Aug 9, 2013·Antioxidants & Redox Signaling·Nerea Hermida, Jean-Luc Balligand
Apr 16, 2014·Clinical Neurology and Neurosurgery·Peiyang ZhouPu Wang
Feb 21, 2014·Heart·Maheshwar PauriahChim C Lang
Mar 8, 2016·Trends in Cardiovascular Medicine·Nikolaos PapageorgiouDimitris Tousoulis
Nov 8, 2011·British Journal of Clinical Pharmacology·Jean Davignon
Nov 19, 2011·Clinical Cardiology·Mohammed Reza MovahedMehrtash Hashemzadeh
Nov 2, 2015·Atherosclerosis·Monica VerdoiaUNKNOWN Novara Atherosclerosis Study Group (NAS)
Dec 24, 2010·Journal of cardiology·Michinari NakamuraUNKNOWN Shinken Database Study Group
Aug 1, 2007·Journal of Vascular Surgery·Kosmas I ParaskevasDimitri P Mikhailidis
Feb 28, 2017·Journal of Atherosclerosis and Thrombosis·Yu KataokaStephen J Nicholls
Mar 5, 2011·The Journal of Medical Investigation : JMI·Miyako KishimotoMitsuhiko Noda
Jan 17, 2017·Annales d'endocrinologie·UNKNOWN French Society of Endocrinology (SFE)B Vergès
Aug 12, 2014·Journal of Pharmacy Practice·Pavel GoriackoRoda Plakogiannis
Sep 10, 2017·European Heart Journal·Borja IbanezUNKNOWN ESC Scientific Document Group
Apr 10, 2018·Circulation Journal : Official Journal of the Japanese Circulation Society·Tatsuya UmedaTamio Teramoto
Sep 30, 2016·Medicine·Hongxi SunBaocheng Chang
Mar 12, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Ali OlyaeiJose Rueda
Dec 21, 2013·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Mary Chester WaskoMahboob U Rahman
Oct 15, 2019·Journal of the American Heart Association·Adam D GepnerCynthia M Carlsson
Aug 25, 2020·Lipids in Health and Disease·Shiyong YuXiaolu Luo